Fig. 3
Forest plot and meta-analysis of visual clarity. (a) Incidence of chemotherapy dose reduction or delays. (b) Requirement of platelet transfusion. (c) Incidence of hemorrhagic events
Fig. 3 | BMC Pharmacology and Toxicology
Forest plot and meta-analysis of visual clarity. (a) Incidence of chemotherapy dose reduction or delays. (b) Requirement of platelet transfusion. (c) Incidence of hemorrhagic events